These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 18045249)

  • 1. Application of proteomic technology in eye research: a mini review.
    Lam TC; Chun RK; Li KK; To CH
    Clin Exp Optom; 2008 Jan; 91(1):23-33. PubMed ID: 18045249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of proteomics in ophthalmic research.
    Steely HT; Clark AF
    Pharmacogenomics; 2000 Aug; 1(3):267-80. PubMed ID: 11256578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tear analysis in ocular surface diseases.
    Zhou L; Beuerman RW
    Prog Retin Eye Res; 2012 Nov; 31(6):527-50. PubMed ID: 22732126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitreous humor in the pathologic scope: insights from proteomic approaches.
    Monteiro JP; Santos FM; Rocha AS; Castro-de-Sousa JP; Queiroz JA; Passarinha LA; Tomaz CT
    Proteomics Clin Appl; 2015 Feb; 9(1-2):187-202. PubMed ID: 25523418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human tear proteomics and peptidomics in ophthalmology: Toward the translation of proteomic biomarkers into clinical practice.
    Azkargorta M; Soria J; Acera A; Iloro I; Elortza F
    J Proteomics; 2017 Jan; 150():359-367. PubMed ID: 27184738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tears as a source of biomarkers for ocular and systemic diseases.
    von Thun Und Hohenstein-Blaul N; Funke S; Grus FH
    Exp Eye Res; 2013 Dec; 117():126-37. PubMed ID: 23880526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteomic analysis of ophthalmic disease.
    Jay NL; Gillies M
    Clin Exp Ophthalmol; 2012; 40(7):755-63. PubMed ID: 22394539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular diagnostics of ocular diseases: the application of antibody microarray.
    Izzotti A; Centofanti M; Saccà SC
    Expert Rev Mol Diagn; 2012 Jul; 12(6):629-43. PubMed ID: 22845483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trends in proteomic analysis of human vitreous humor samples.
    Rocha AS; Santos FM; Monteiro JP; Castro-de-Sousa JP; Queiroz JA; Tomaz CT; Passarinha LA
    Electrophoresis; 2014 Sep; 35(17):2495-508. PubMed ID: 24825767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unraveling the molecular repertoire of tears as a source of biomarkers: beyond ocular diseases.
    Pieragostino D; D'Alessandro M; di Ioia M; Di Ilio C; Sacchetta P; Del Boccio P
    Proteomics Clin Appl; 2015 Feb; 9(1-2):169-86. PubMed ID: 25488355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of tear fluid biomarkers in dry eye syndrome using iTRAQ quantitative proteomics.
    Zhou L; Beuerman RW; Chan CM; Zhao SZ; Li XR; Yang H; Tong L; Liu S; Stern ME; Tan D
    J Proteome Res; 2009 Nov; 8(11):4889-905. PubMed ID: 19705875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The microarray: potential applications for ophthalmic research.
    Wilson AS; Hobbs BG; Speed TP; Rakoczy PE
    Mol Vis; 2002 Jul; 8():259-70. PubMed ID: 12131875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteomics and diabetic retinopathy.
    Merchant ML; Klein JB
    Clin Lab Med; 2009 Mar; 29(1):139-49. PubMed ID: 19389556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic isolates in ophthalmic diseases.
    Sherwin JC; Hewitt AW; Ruddle JB; Mackey DA
    Ophthalmic Genet; 2008 Dec; 29(4):149-61. PubMed ID: 19005985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The potential impact of recent insights into proteomic changes associated with glaucoma.
    Funke S; Perumal N; Bell K; Pfeiffer N; Grus FH
    Expert Rev Proteomics; 2017 Apr; 14(4):311-334. PubMed ID: 28271721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Review of proteomics approach to eye diseases affecting the anterior segment.
    Aghamollaei H; Parvin S; Shahriary A
    J Proteomics; 2020 Aug; 225():103881. PubMed ID: 32565161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteomic technology and its biomedical applications.
    Lau AT; He QY; Chiu JF
    Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2003 Nov; 35(11):965-75. PubMed ID: 14614532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein Microarrays for Ocular Diseases.
    Solís-Fernández G; Montero-Calle A; Alonso-Navarro M; Fernandez-Torres MÁ; Lledó VE; Garranzo-Asensio M; Barderas R; Guzman-Aranguez A
    Methods Mol Biol; 2021; 2344():239-265. PubMed ID: 34115364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Human Eye Proteome Project: perspectives on an emerging proteome.
    Semba RD; Enghild JJ; Venkatraman V; Dyrlund TF; Van Eyk JE
    Proteomics; 2013 Aug; 13(16):2500-11. PubMed ID: 23749747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective Application of Activity-Based Proteomic Profiling in Vision Research-Potential Unique Insights into Ocular Protease Biology and Pathology.
    Peng H; Hulleman JD
    Int J Mol Sci; 2019 Aug; 20(16):. PubMed ID: 31398819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.